Literature DB >> 6325430

Platelet-derived growth factor receptors form a high affinity state in membrane preparations. Kinetics and affinity cross-linking studies.

L T Williams, P M Tremble, M F Lavin, M E Sunday.   

Abstract

The specific binding of 125I-PDGF (platelet-derived growth factor) to intact fibroblasts becomes relatively nondissociable during incubation at 37 degrees C. To characterize the interaction of PDGF with its receptors under conditions in which there is no receptor internalization, we have studied the binding of 125I-PDGF to membrane preparations derived from mouse 3T3 cells and rat liver. The binding sites had the affinity and specificity characteristics expected of PDGF receptors. At 37 degrees C (but not at 4 degrees C) the specific binding of 125I-PDGF to membranes gradually became nondissociable as assessed by either dilution or by addition of excess unlabeled PDGF. This tight binding was not due to a covalent interaction since the polyanionic compound suramin readily dissociated specifically bound 125I-PDGF. This property of suramin was used to expose rat liver PDGF receptors which were occupied by endogenous PDGF. Affinity cross-linking studies demonstrated that the formation of the nondissociable state of 125I-PDGF binding was associated with the binding of 125I-PDGF to a 160,000-dalton protein and to a 110,000-dalton species. The cross-linked binding sites could be adsorbed to wheat germ agglutinin and to anion exchange resins. The isoelectric point of both cross-linked species determined by two-dimensional gel electrophoresis was approximately 4.7. These data demonstrate that in membrane preparations, PDGF binds to an anionic 160,000-dalton glycoprotein which is likely to be the receptor. A high affinity state of PDGF binding, which is formed rapidly at 37 degrees C, can be dissociated by suramin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325430

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Isolation of antibodies for phosphotyrosine by immunization with a v-abl oncogene-encoded protein.

Authors:  J Y Wang
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

Review 2.  Platelet-derived growth factor: mechanism of action and possible in vivo function.

Authors:  C H Heldin; B Westermark
Journal:  Cell Regul       Date:  1990-07

3.  Modulation of platelet-derived growth factor receptor expression in microvascular endothelial cells during in vitro angiogenesis.

Authors:  M Marx; R A Perlmutter; J A Madri
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

4.  Secreted int-1 protein is associated with the cell surface.

Authors:  J Papkoff; B Schryver
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

5.  Purification of the platelet-derived growth factor receptor by using an anti-phosphotyrosine antibody.

Authors:  T O Daniel; P M Tremble; A R Frackelton; L T Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

6.  Experimental approaches to hypothetical hormones: detection of a candidate ligand of the neu protooncogene.

Authors:  Y Yarden; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

7.  Suramin inhibits binding and degradation of platelet-derived growth factor in arterial smooth muscle cells but does not interfere with autocrine stimulation of DNA synthesis.

Authors:  M Sjölund; J Thyberg
Journal:  Cell Tissue Res       Date:  1989-04       Impact factor: 5.249

8.  Differentiation induction of mouse embryonic stem cells into sinus node-like cells by suramin.

Authors:  Cornelia Wiese; Teodora Nikolova; Ihor Zahanich; Sabine Sulzbacher; Joerg Fuchs; Satoshi Yamanaka; Eva Graf; Ursula Ravens; Kenneth R Boheler; Anna M Wobus
Journal:  Int J Cardiol       Date:  2009-09-22       Impact factor: 4.164

9.  Hepatic protein tyrosine phosphatases in the rat.

Authors:  P A Gruppuso; J M Boylan; B L Smiley; R J Fallon; D L Brautigan
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

10.  Biphasic effects of suramin on 125I-epidermal growth factor binding to human meningiomas.

Authors:  K Tsutsumi; N Kitagawa; M Niwa; S Yamaga; H Khalid; K Taniyama; A Himeno; S Shibata
Journal:  Cell Mol Neurobiol       Date:  1993-12       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.